BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2101804)

  • 1. Clinical value of cytomorphologic, immunologic and cytogenetic investigations of acute leukaemias.
    Pálóczi K; Natonek K; Mód A; Poros A; Földi J; Magyar M; Mihalik R; Szelényi J; Benczur M; Hollán SR
    Haematologia (Budap); 1990; 23(4):199-209. PubMed ID: 2101804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytochemical, immunologic and gene rearrangement studies in adult acute leukemia].
    Pálóczi K; Natonek K; Mód A; Poros A; Mihalik R; Földi J; Benczur M; Hollán Z
    Orv Hetil; 1990 May; 131(21):1119-24. PubMed ID: 2194149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J; López-Karpovitch X; Cárdenas MR
    Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotyping with flow cytometry in patients with acute leukemia].
    Mociková H; Mociková K; Wildová B; Kohútová M; Bubanská E
    Vnitr Lek; 1996 Jul; 42(7):454-7. PubMed ID: 8928420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukaemia immunophenotyping in bone-marrow routine sections.
    Pileri SA; Ascani S; Milani M; Visani G; Piccioli M; Orcioni GF; Poggi S; Sabattini E; Santini D; Falini B
    Br J Haematol; 1999 May; 105(2):394-401. PubMed ID: 10233410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
    Merle-Béral H; Boucheix C
    Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
    Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgH and TCRgamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias.
    Golemović M; Sucić M; Zadro R; Mrsić S; Mikulić M; Labar B; Rajić LJ; Batinić D
    Leuk Res; 2006 Feb; 30(2):211-21. PubMed ID: 16102826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
    Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
    Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene rearrangements in T-cell lymphoblastic lymphoma.
    Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
    J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
    Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
    Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.